Thrombocytopenia in adult patients with sepsis: Incidence, risk factors, and its association with clinical outcome

Journal of Intensive Care

Volumn 1, Issue 1, 2013, Pages

  Venkata, Chakradhar ^a   Kashyap, Rahul ^a   Christopher Farmer, J ^b   Afessa, Bekele ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Intensive care unit; Mortality; Prognosis; Sepsis; Septic shock; Thrombocytopenia

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; APACHE; ARTICLE; BLEEDING; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SEPTIC SHOCK; THROMBOCYTOPENIA;

EID: 84991031123     PISSN: None     EISSN: 20520492     Source Type: Journal    
DOI: 10.1186/2052-0492-1-9     Document Type: Article

References (40)

1. Drews RE, Weinberger SE: Thrombocytopenic disorders in critically ill patients. Am J Respir Crit Care Med 2000, 162:347-351.
2. Stephan F, Hollande J, Richard O, Cheffi A, Maier-Redelsperger M, Flahault A: Thrombocytopenia in a surgical ICU. Chest 1999, 115:1363-1370.
3. Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H: Thrombocytopenia and prognosis in intensive care. Crit Care Med 2000, 28:1871-1876.
4. Akca S, Haji-Michael P, de Mendonca A, Suter P, Levi M, Vincent JL: Time course of platelet counts in critically ill patients. Crit Care Med 2002, 30:753-756.
5. Bonfiglio MF, Traeger SM, Kier KL, Martin BR, Hulisz DT, Verbeck SR: Thrombocytopenia in intensive care patients: a comprehensive analysis of risk factors in 314 patients. Ann Pharmacother 1995, 29:835-842.
6. Cawley MJ, Wittbrodt ET, Boyce EG, Skaar DJ: Potential risk factors associated with thrombocytopenia in a surgical intensive care unit. Pharmacotherapy 1999, 19:108-113.
7. Shalansky SJ, Verma AK, Levine M, Spinelli JJ, Dodek PM: Risk markers for thrombocytopenia in critically ill patients: a prospective analysis. Pharmacotherapy 2002, 22:803-813.
8. Sharma B, Sharma M, Majumder M, Steier W, Sangal A, Kalawar M: Thrombocytopenia in septic shock patients-a prospective observational study of incidence, risk factors and correlation with clinical outcome. Anaesth Intensive Care 2007, 35:874-880.
9. Abraham E, Anzueto A, Gutierrez G, Tessler S, San Pedro G, Wunderink R, Dal Nogare A, Nasraway S, Berman S, Cooney R, Levy H, Baughman R, Rumbak M, Light RB, Poole L, Allred R, Constant J, Pennington J, Porter S: Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II study group. Lancet 1998, 351:929-933.
10. Cohen J, Carlet J: INTERSEPT: an international, multicenter, placebocontrolled trial of monoclonal antibody to human tumor necrosis factoralpha in patients with sepsis. International sepsis trial study group. Crit Care Med 1996, 24:1431-1440.
11. Eisele B, Lamy M, Thijs LG, Keinecke HO, Schuster HP, Matthias FR, Fourrier F, Heinrichs H, Delvos U: Antithrombin III in patients with severe sepsis: a randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intensive Care Med 1998, 24:663-672.
12. Fisher CJ Jr, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E: Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The soluble TNF receptor sepsis study group. N Engl J Med 1996, 334:1697-1702.
13. Herasevich V, Kor DJ, Li M, Pickering BW: ICU data mart: a non-iT approach. A team of clinicians, researchers and informatics personnel at the Mayo clinic have taken a homegrown approach to building an ICU data mart. Healthc Inform 2011, 28(42):44-45.
14. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care 2004, 8:R204-R212.
15. Priziola JL, Smythe MA, Dager WE: Drug-induced thrombocytopenia in critically ill patients. Crit Care Med 2010, 38:S145-S154.
16. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG: Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 2002, 30:1765-1771.
17. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest 1992, 101:1644-1655.
18. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC: The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010, 38:367-374.
19. Calandra T, Cohen J: The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005, 33:1538-1548.
20. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R: The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
21. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001, 86:1327-1330.
22. Warkentin TE, Heddle NM: Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2003, 2:148-157.
23. George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, Vondracek T: Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med 1998, 129:886-890.
24. Graafsma YP, Prins MH, Lensing AW, de Haan RJ, Huisman MV, Buller HR: Bleeding classification in clinical trials: observer variability and clinical relevance. Thromb Haemost 1997, 78:1189-1192.
25. Thakur L, Kojicic M, Thakur SJ, Pieper MS, Kashyap R, Trillo-Alvarez CA, Javier F, Cartin-Ceba R, Gajic O: Alcohol consumption and development of acute respiratory distress syndrome: a population-based study. Int J Environ Res Public Health 2009, 6:2426-2435.
26. Gafter-Gvili A, Mansur N, Bivas A, Zemer-Wassercug N, Bishara J, Leibovici L, Paul M: Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importance. Mayo Clin Proc 2011, 86:389-396.
27. Lee KH, Hui KP, Tan WC: Thrombocytopenia in sepsis: a predictor of mortality in the intensive care unit. Singapore Med J 1993, 34:245-246.
28. Oguzulgen IK, Ozis T, Gursel G: Is the fall in platelet count associated with intensive care unit acquired pneumonia? Swiss Med Wkly 2004, 134:430-434.
29. Vandijck DM, Blot SI, De Waele JJ, Hoste EA, Vandewoude KH, Decruyenaere JM: Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung 2010, 39:21-26.
30. Gawaz M, Dickfeld T, Bogner C, Fateh-Moghadam S, Neumann FJ: Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med 1997, 23:379-385.
31. Mavrommatis AC, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-Kokkinou V, Zakynthinos S: Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 2000, 28:451-457.
32. Ghosh TK, Khan N, Malik A: Platelet auto-antibodies in septicaemic patients. Indian J Pathol Microbiol 1999, 42:31-35.
33. Francois B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H: Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med 1997, 103:114-120.
34. Stephan F, Thioliere B, Verdy E, Tulliez M: Role of hemophagocytic histiocytosis in the etiology of thrombocytopenia in patients with sepsis syndrome or septic shock. Clin Infect Dis 1997, 25:1159-1164.
35. Aird WC: The hematologic system as a marker of organ dysfunction in sepsis. Mayo Clin Proc 2003, 78:869-881.
36. Cserti CM, Landaw S, Uhl L: Do infections provoke exacerbations and relapses of thrombotic thrombocytopenic purpura? J Clin Apher 2007, 22:21-25.
37. Douglas KW, Pollock KG, Young D, Catlow J, Green R: Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: a single-institution experience. J Clin Apher 2010, 25:47-53.
38. Crowther MA, Cook DJ, Meade MO, Griffith LE, Guyatt GH, Arnold DM, Rabbat CG, Geerts WH, Warkentin TE: Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. J Crit Care 2005, 20:348-353.
39. Brogly N, Devos P, Boussekey N, Georges H, Chiche A, Leroy O: Impact of thrombocytopenia on outcome of patients admitted to ICU for severe community-acquired pneumonia. J Infect 2007, 55:136-140.
40. Nijsten MW, ten Duis HJ, Zijlstra JG, Porte RJ, Zwaveling JH, Paling JC, The TH: Blunted rise in platelet count in critically ill patients is associated with worse outcome. Crit Care Med 2000, 28:3843-3846.